Home › India board rules against Bayer in cancer drug patent case
 

Keywords :   


India board rules against Bayer in cancer drug patent case

2013-03-04 18:53:06| Chemicals - Topix.net

An Indian patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.

Tags: case board rules india

Category:Chemicals

Latest from this category

All news
07.11Graco Completes Previously-Announced Acquisition of Corob
07.11PPG MOONWALK Paint Mixing System Now Has Customers in All 50 U.S. States
07.11 Arxada to Exhibit New Technology & Capabilities at Paints & Coatings Barcelona 2024
07.11BioMADE Announces $26.9 Million Invested in 17 Projects
07.11NanoTech Materials Named to TIMEs List of the Best Inventions of 2024
06.11Graco Inc. Completes Acquisition of Corob S.p.A.
06.11Tnemec Names Mike Branch New Sales Director of National Accounts
06.11AkzoNobel Sponsors Mural at YMCA Warsaw, IN
Chemicals »
07.11Lawsuit over FDA's regulatory approval process for carbadox dismissed
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 16
07.11Hurricane Rafael Wind Speed Probabilities Number 16
07.11Hurricane Rafael Forecast Advisory Number 16
07.11Hurricane Rafael Public Advisory Number 16
07.11Summary for Hurricane Rafael (AT3/AL182024)
07.11Tropical Depression Fourteen-E Graphics
More »